London < Long-Term Care < Long-Term Potentiation

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 26.
[0-20] [0 - 20][0 - 26][20-25][20-40]

Ident.	Authors (with country if any)	Title
000273 (2000)	H H Fernandez [États-Unis] ; K L Lapane ; B R Ott ; J H Friedman	Gender differences in the frequency and treatment of behavior problems in Parkinson's disease. SAGE Study Group. Systematic Assessment and Geriatric drug use via Epidemiology.
000315 (2000)	D. Tarsy [États-Unis] ; N. Bhattacharyya ; G. Borodic	Myasthenia gravis after botulinum toxin A for Meige syndrome.
000843 (2002)	Marcelo Merello [Argentine] ; Maria I. Nouzeilles ; Gabriel Piran Arce ; Ram N Leiguarda	Accuracy of acute levodopa challenge for clinical prediction of sustained long-term levodopa response as a major criterion for idiopathic Parkinson's disease diagnosis.
000934 (2002)	Alice J. Manson [Royaume-Uni] ; Kirsten Turner ; Andrew J. Lees	Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease: long-term follow-up study of 64 patients.
000942 (2002)	G-Y R. Hsiung [Canada] ; S K Das ; R. Ranawaya ; A-L Lafontaine ; O. Suchowersky	Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period.
000C97 (2004)	Susan Hollán [Hongrie] ; Lászl Vécsei ; Kálmán Magyar	Adverse effects of dopamine potentiation by long-term treatment with selegiline.
001438 (2006)	Emmanuel Roze [Suisse] ; Marie Vidailhet ; Nenad Blau ; Lisbeth Birk Moller ; Diane Doummar ; Thierry Billette De Villemeur ; Anne Roubergue	Long-term follow-up and adult outcome of 6-pyruvoyl-tetrahydropterin synthase deficiency.
001716 (2006)	Claudia Trenkwalder [Allemagne] ; Karin Stiasny-Kolster ; Andreas Kupsch ; Wolfgang H. Oertel ; Juergen Koester ; Juergen Reess	Controlled withdrawal of pramipexole after 6 months of open-label treatment in patients with restless legs syndrome.
001798 (2006)	Jacques Montplaisir [Canada] ; Jeff Karrasch ; Jean Haan ; Dieter Volc	Ropinirole is effective in the long-term management of restless legs syndrome: a randomized controlled trial.
001D81 (2007)	Cristiane Fiquene Conti [Brésil] ; Márcio Moysés De Oliveira ; Regis Bruni Andriolo ; Humberto Saconato ; Alvaro Nagib Atallah ; Juliana Spelta Valbuza ; Luciane Bizari Coin De Carvalho ; Gilmar Fernandes Do Prado	Levodopa for idiopathic restless legs syndrome: evidence-based review.
001D85 (2007)	Matthew O. Hebb [Canada] ; Paula Chiasson ; Anthony E. Lang ; Robert M. Brownstone ; Ivar Mendez	Sustained relief of dystonia following cessation of deep brain stimulation.
002111 (2008)	Pedro J. García Ruiz [Espagne] ; Angel Sesar Ignacio ; Bego A Ares Pensado ; Alfonso Castro García ; Fernando Alonso Frech ; Mercedes Alvarez L Pez ; José Arbelo González ; Joan Baiges Octavio ; Juan Andrés Burguera Hernández ; Matilde Calopa Garriga ; Dulce Campos Blanco ; Belén Casta O García ; Manuel Carballo Cordero ; José Chac N Pe A ; Anna Espino Ibá Ez ; Aránzazu Gorospe Onisalde ; Santiago Giménez-Roldán ; Pilar Granés Ibá Ez ; Jorge Hernández Vara ; Ram N Ibá Ez Alonso ; Félix Javier Jiménez Jiménez ; Jerzy Krupinski ; Jaime Kulisevsky Bojarsky ; Inés Legarda Ramírez ; Elena Lezcano García ; Juan Carlos Martínez-Castrillo ; Dolores Mateo González ; Francesc Miquel Rodríguez ; Pablo Mir ; Elena Mu Oz Fargas ; José Obeso Inchausti ; Jesús Olivares Romero ; José Olivé Plana ; Pilar Otermin Vallejo ; Berta Pascual Sedano ; Víctor Pérez De Colosía Rama ; Isabel Pérez L Pez-Fraile ; Albert Planas Comes ; Víctor Puente Periz ; María Cruz Rodríguez Oroz ; Dolores Sevillano García ; Pilar Solís Pérez ; José Suárez Mu Oz ; Julia Vaamonde Gamo ; Caridad Valero Merino ; Francesc Valldeoriola Serra ; José Miguel Velázquez Pérez ; Rosa Yá Ez Ba A ; Ivana Zamarbide Capdepon	Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: a multicenter study.
003186 (2011)	Sudhansu Chokroverty [États-Unis]	Long-term management issues in restless legs syndrome.
004818 (1994)	J P Bennett ; E R Landow ; S. Dietrich ; L A Schuh	Suppression of dyskinesias in advanced Parkinson's disease: moderate daily clozapine doses provide long-term dyskinesia reduction.
004823 (1994)	J M Trugman ; R. Leadbetter ; M E Zalis ; R O Burgdorf ; G F Wooten	Treatment of severe axial tardive dystonia with clozapine: case report and hypothesis.
004908 (1994)	S. Rose [Royaume-Uni] ; P. Jenner ; C D Marsden	Chronic administration does not alter the accumulation of L-dopa into muscle.
004914 (1994)	T. Mendis [Canada] ; E. Mohr ; A. George ; I N Rusk ; P. Gray ; J D Grimes	Symptomatic relief from treatment-induced psychosis in Parkinson's disease: an open-label pilot study with remoxipride.
004994 (1993)	P. Martínez-Martín	Transient dyskinesia induced by clebopride.
004A11 (1993)	A J Hughes [Royaume-Uni] ; S. Bishop ; B. Kleedorfer ; N. Turjanski ; W. Fernandez ; A J Lees ; G M Stern	Subcutaneous apomorphine in Parkinson's disease: response to chronic administration for up to five years.
004B04 (1996)	K J Bharucha [États-Unis] ; K D Sethi	Complex movement disorders induced by fluoxetine.
004B50 (1996)	M. Ossemann ; C J Sindic ; C. Laterre	Tetrabenazine as a cause of neuroleptic malignant syndrome.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i -k "Long-Term Care" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i  \
                -Sk "Long-Term Care" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Long-Term Care
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024